Stock Analiz

Ibotta, Inc. IBTA

Advertising · IPO 2024 · data as of November 13, 2026

$57.59Market cap $1.3B
Open the interactive analysis →

Ibotta, Inc. (IBTA) is a consumer discretionary company listed in the US with a market value of about $1.3B. In the twelve months to September 30, 2026 it had revenue of $358M and net income of -$16M, a net margin of -4.5%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is financial health (4/5); the weakest is shareholder returns (0/5).

Key numbers: a price to free cash flow of 16.6, a 5-year average ROIC of 18%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 82% below the current price.

Score: 1.6 / 5

Value1/5
Future growth2/5
Track record1/5
Financial health4/5
Shareholder returns0/5

Checks passed

  • P/FCF below 20
  • 3-year revenue growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year average ROIC above 12%
  • More cash than debt, or low debt to equity
  • Positive free cash flow
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E30.0
P/FCF16.6
P/S3.8
P/B5.7
EV/EBITDA436.8
PEG—
Dividend yield0.00%
FCF yield6.0%
Shareholder yield17.3%
Intrinsic value vs. price−82%

Growth and quality

Revenue growth (1 yr)-6.8%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)1.4%
ROIC (5-yr avg.)18.4%
Profitable years (of last 10)3
Years paying a dividend—

Financials, last 4 years

Fiscal yearTTM2025202420232022
Revenue$358M$342M$367M$320M$211M
Net income-$16M$4M$69M$38M-$55M
Free cash flow$81M$75M$115M$22M-$57M
EPS (diluted)$-0.66$0.12$2.56$1.42$-6.33
Net margin-4.5%1.0%18.7%11.9%-26.0%
ROIC—-0.2%4.8%50.6%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 7 analysts is $50.57, 12% below the current price; targets range from $26.00 to $65.00; the consensus rating is “Hold”; expected EPS is $1.83 for the fiscal year ending December 31, 2026.

Frequently asked questions

Is Ibotta stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 82% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Ibotta pay a dividend?

Not currently.

Is Ibotta a good stock to buy?

We do not give buy or sell advice. Ibotta scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.